HD-OPM Archive
Topics › Plaque, CAC & CT angiography

Does a CAC scan change outcomes? Two 2026 randomized trials say not for the average person

Louis Nervegna · Sep 04, 2026 · ♥ 8 reactions · 31 comments · original Facebook post
Plaque, CAC & CT angiographyRisk assessment & lab tests
AI summary & key facts

Louis asks whether CAC scanning changes whether you have a heart attack; for some it is a wake-up call, but for the average person it does not seem to change outcomes. The shared text cites a Danish trial of 30,000 men (no reduction in death, MI or stroke at seven years, more serious bleeding) and the US CorCal trial of nearly 6,000 people (same event rates as a risk calculator).

Does getting a CAC scan actually change whether or not you ultimately have a heart attack?

For some people, it is a wake up call and a life saver.

But for the average person, it doesn’t seem to change outcomes.

#cacHD

Research cited

Scan or scam? A calcium scan tells you plaque exists. No trial has shown it helps anyone, and it’s being sold to everyone. Two randomized trials this year say it does not change whether you live or have a heart attack: a Danish trial of 30,000 men screened with CAC showed no reduction in death, MI, or stroke at seven years and more serious bleeding (Lindholt JS et al, Eur Heart J 2026), and a US trial of nearly 6,000 people using CAC to guide statin decisions found identical event rates to a plain risk calculator (Muhlestein JB et al, CorCal Outcomes, ESC Congress 2026). The US Preventive Services Task Force does not recommend it for routine risk assessment in asymptomatic adults, citing insufficient evidence that it prevents events and the cardiology guidelines give the test one job: helping decide on a statin when the risk is borderline. Everything else is marketing. Remember, I’m a doctor, just not your doctor. Talk to your own doctor about your own risk and medical decision making.

#heartattack#statins#calcium#plaque#stroke#bleeding#calculator#prevent
← newer: Plaque regression is real: Louis links the randomized trialsolder: High blood xylitol linked to 57% higher MACE risk in observa →